The adaptation of allogeneic chimerism in treatment of autoimmune diabetes has been shown as a promising approach in numerous studies in both experimental and clinical settings. Establishment of hemopoietic chimerism in NOD mice is the most adequate animal model to study mechanisms involved in the multiple aspects of the curative effects of chimerism in autoimmunity-prone individuals. However, there are some discrepancies in the current literature for parameters and criteria used to characterize chimerism in the NOD model. This study was aimed to standardize the criteria for the different pathological stages of diabetogenesis in chimeric versus unmanipulated NOD mice. We report two well-defined scoring systems and a new Index N for the assessment of the pathological characteristics of diabetogenesis and GVHD in chimeric NOD mice. Also, we have demonstrated that, in the NOD model, recipient conditioning resulting in as low as 1% of chimerism is sufficient to promote engraftment of the BM donor-specific islets of Langerhans.
INTRODUCTION
fairly standard, and (ii) morphometrical analysis of the diabetic chimerae tissues, which is not. We report the results of our study directed to stan-The NOD mouse is one of the most legitimate animal models of type I diabetes (31). It is widely used in stud-dardize the criteria for the assessment of the diabetic endocrine pancreas upon establishment of hemopoietic ies directed to evaluate hemopoietic chimerism as a possible approach for the therapeutic intervention in insulin-chimerism. Our detailed description and methodology to define different pathological stages of diabetogenesis in dependent diabetes mellitus (IDDM) patients (7, 17, 18, 21, 29) . In numerous studies it has been demonstrated chimeric versus unmanipulated NOD mice could be useful for future studies aimed to optimize a BMT protocol that hemopoietic chimerism can arrest the progression of diabetogenesis (3, 6, 8, 12, 32) , and bone marrow trans-for its clinical application in treatment of diabetes. plantation (BMT) was reported as an adjuvant for pancreas and islet allograft survival in the therapy for dia-MATERIALS AND METHODS betic patients (2,4). Moreover, in light of our data and Mice that of others (30, 35) which show that chimerism, even at a minimal level (35) , has the potential to promote the full NOD/MrkTacfBr and C57BL/6J (B6) mice were purfunctional recovery of the endogenous insulin regulation, chased from Taconic Biotechnology; C57BL/10J (B10) the perspective to adapt hemopoietic chimerism for treatand B10BR/SgSn (BR) were obtained from the Jackson ment of diabetes is certainly worth further exploration.
Laboratory. Animals were housed in the Animal Facility However, there are some discrepancies in the current at Children's Hospital of Pittsburgh under specific patholiterature for criteria used to characterize chimerism in gen-free conditions. the NOD model. The basic parameters used to assess Preparation of Allogeneic Chimerae both therapeutic efficacy of the hemopoietic chimerism and symptoms of graft versus host disease (GVHD), Our basic protocol was adapted from the one previously described (10) and applied with the following which is one of the major side effects of BMT, are (i) their clinical manifestations, evaluation of which is modifications. NOD recipient mice, at different ages ac-cording to the particular experiment, were gamma irradi-engraftment two-color staining was carried out using both antidonor and antirecipient MHC class I and lineage-ated with a nonlethal (700 cGy) dose of total body irradiation (TBI) and were reconstituted within 5 h via an specific antibodies (Abs), such as: myeloid (GR-1), T cells (αβTCR), B cells (CD19), and dendritic cells (CD11c). IV injection of various doses of T-depleted bone marrow (BM). For T-cell depletion a rabbit-anti-mouse brain Flow analysis was performed on a Becton Dickinson dual laser FACSCalibur. All mAbs were purchased from (RAMB) polyclonal serum (Inter-Cell Technologies, Inc., Somerville, NJ) and guinea pig complement were used.
BD PharMingen (San Diego, CA).
Immunohistochemical Protocols Islet of Langerhans Transplantation
To reveal insulin-positive cells, 5-µm paraffin sec-Islets were harvested from B6 or BR donors and tions of formalin-fixed kidneys with engrafted islets transplanted into chimeric (NOD/B10) animals. Pancrewere stained with anti-mouse insulin mAb (BioGenex atic islet isolation was performed using a modified colla-Lab., San Ramon, CA) using the ABC method. All secgenase digestion procedure (15, 20) . Briefly, 3 ml of cold tions were also counterstained with hematoxylin. Hanks solution containing 2.0 mg/ml of collagenase (Sigma-Aldrich, St. Louis, MO) was injected into the Microscopic Evaluation of GVHD pancreatic duct. After pancreatectomy the islets were Specimens were collected from the euthanized anipurified from the digested tissue by density gradient cell mals from the middle of the ear (skin), tongue, and from separation using Ficoll gradients (1.108, 1.096, 1.069, the middle of left lateral lobe of the liver. Two samples and 1.037) (Sigma, St. Louis, MO) and hand-counted were prepared from each harvested organ. One was under a stereomicroscope. Each NOD mouse received fixed in neutral-buffered formalin for 2-3 days, rouapproximately 350 islets transplanted beneath the left retinely processed, and embedded in paraffin, and the nal capsule. Graft acceptance and function were moniother embedded in O.C.T. compound (Miles Laboratored by testing blood and urine glucose levels, and by tories, Elkhart, IN), snap frozen in liquid nitrogen, and histological examination of the renal subcapsular grafts stored at −80°C until used. for insulitis and insulin content. At the time of kidney Paraffin sections (5 µm) were prepared from the parharvesting, a pigmented dye was used to mark the locaaffin blocks and stained with hematoxylin-eosin (H&E). tion of the transplanted islets to ensure the appropriate A scoring system based on previous reports for evaluahistological sectioning through the graft.
tion of the GVHD-associated liver damage (26-28) was developed following the criteria listed in Table 2 . The Urine Glucose Measurement minimal, moderate, and significant manifestations were Urine from the chimeric animals and from age-matched graded with numbers 1, 2, and 3, respectively, for all controls was tested for glucosuria weekly with Ketobut bile duct pathology and zonal parenchymal necrosis. Diastix  (Baxter, Elkhart, IN). A positive test for glucos-The latter was graded as central, 3; periportal, 5; and uria was considered symptomatic for the clinical onset bridging, 7. Bile duct pathology was graded for damage of diabetes. and disarrangement with 3 and 0.5 for minimal, 4 and 1 for moderate, and 5 and 2 for significant, respectively.
Blood Glucose Measurement
The grades were totaled and a score greater than 5 was A pen-type glucometer (Precision QID, Medisense) considered as a morphologic indication of GVHD. was used to measure blood glucose from tail vein sam-To determine if donor-derived cells are present in the ples, and was expressed in mg/dl glucose. Normal mumononuclear cell infiltration, immunohistochemical stainrine blood glucose level ranges from 75 to 120 mg/dl. ing of frozen biopsy specimens was performed with anti-Mice were considered diabetic with a level of 300 mg/ donor MHC class I Ab. Sections (5-7 µm) were predl or above for two consecutive daily readings. pared using a cryostat Microm HM 505 N (Carl Zeiss, Goettingen, Germany), mounted on charged precleaned Characterization of Chimerae by Flow Cytometry slides (Fisher Scientific), air-dried overnight at room temperature, and followed by standard procedures for The level of chimerism was assessed by flow cytometry as a percentage of peripheral blood leukocytes (PBL) immunohistochemical staining of frozen sections. Briefly, the cryostat sections were fixed in cold acetone, air-bearing donor and host MHC class I molecules (H-2K b for B10 and H-2K d for NOD) after staining with directly dried, and washed in phosphate-buffered saline (PBS). After blocking for endogenous peroxidase activity and labeled fluorescent H-2K b and H-2K d monoclonal antibody (mAb). To isolate leukocytes from the peripheral application of protein blocker, sections were incubated with primary Abs (Biotinylated mouse anti-mouse H-blood a red cell lysing procedure was applied (RCL Buffer, Sigma). To confirm the multilineage hemopoietic 2K b abd H-2K d , BD PharMingen) in a humid chamber at room temperature. Then slides were washed and incu-Index N, a New Parameter to Estimate the Overall Damage of Islets That Integrates Both Insulitis bated with peroxidase enzyme streptavidin/HRP and with chromagen/substrate AEC (both purchased from and the Volume of Unimpaired β-Cell Tissue in NOD Allogeneic Chimerae ScyTek Labs, Logan, UT). Microscopic examination, as well as photomicrography, was performed using an A number of different morphometric approaches have OLYMPUS microscope model BX40 with microphoto been reported to evaluate the destruction of islet tissue OM system (Olympus, Japan) and an Axioplan-2 microand the assessment of insulitis in NOD mice (9, 16, 19, 33) . scope with AxioCam digital camera (both from Carl Utilizing some elements from these studies we designed Zeiss). a new morphometric system for a better assessment of the pathological features of diabetogenesis in the islets Evaluation of the Damage to Pancreatic Islets of Langerhans in chimeric NOD mice. In paraffin sec-Paraffin sections of the pancreata were subjected to tions of the pancreata, the level of insulitis was estimorphometric analysis. The level of insulitis was estimated according to the scoring system described above mated according to a scoring system with grades of se-( Fig. 1 , Table 1 ). Then a measure of the pathology-free verity ranging from 0 to 6 (see Results, Fig. 1 ). As an area of islets versus whole pancreatic tissue was asadditional measure, the area of pathology-free islets versessed and presented as a relative number "A." A need sus the entire pancreatic tissue was calculated and reprefor this new parameter "A" arose from our observation sented by a relative number "A." In order to estimate that in diabetic NOD mice rendered hemopoietic chi-"A," each pancreas was evaluated using 3-6 H&Emerae, a new morphological state of the endocrine panstained sections obtained 50 µm apart. The slides were creas can be recognized (35) . Insulitis is cleared (preexamined using an optical grid with 314 divisions per sumably due to abrogation of the autoimmune process), field. At a magnification of 200×, each division repreand histologically this state is reflected as "no insulitis sented 1 mm 2 of tissue. The area occupied by islets that condition." This insulitis-free state, however, can be diswere free of insulitis and apoptosis was summed over tinguished from the normal, physiological condition of 20 fields and averaged over three replicate assessments. the pancreas. In fact, the islets in the diabetic chimeric In a few specimens serial sections of pancreata were NOD mice, although almost totally cleared from insulistained with H&E and with anti-insulin mAb. Microstis, are significantly reduced in size, display an altered copy of these slides was performed blindly to confirm morphology, and contain cells with little to no insulin our assessment of "normal," nonaffected β-cell mass in content ( Fig. 2A, B ). These mice should be kept alive H&E preparations. In euglycemic NOD mice the value by either parenteral insulin administrations or by islet of "A" was over 100 (with the majority from 200 to transplantation. Thus, both characteristics [i.e., insulitis 300). Only when these two parameters, insulitis score score and the fraction of the unaffected endocrine panand the morphometric measure "A," are combined in a creas (A) combined together] objectively reflect the relative Index "N" (N = insulitis score/A), do they oboverall status of endocrine pancreas in diabetic chimerjectively reflect the overall condition of the islets of ae. A scale faithfully reflecting the stage of diabetogen-Langerhans. The t-test for independent samples was esis defined by a relative Index N (N = insulitis score/ used to determine statistical significance of our compari-A) could then be adopted in mice: (i) not affected (N < sons. 0.01), (ii) remaining euglycemic while destruction of islets was in progress (0.01 < N < 0.06), and (iii) overtly RESULTS diabetic (N > 0.06). In unmanipulated young animals, A Detailed Score to Assess the Progress of Insulitis Index N was generally below 0.01. The interval from in the Islets of Langerhans During Diabetogenesis 0.01 to 0.06 reflected the different stages of the destruc-Although there is no discrepancy on the general contive process of endocrine pancreatic tissue. Animals cept that insulitis progresses with diabetogenesis, the with Index N > 0.06 displayed hyperglycemia. The rate quantitative estimation of the invasive cells varies sigand kinetics of islet of Langerhans damage in unmanipunificantly among the publications. We are suggesting the lated NOD mice of different ages were used as control. use of a score consisting of 6 grades ( Fig. 1 , Table 1 ) characterizing in more detail all steps of this pathogenic A Distinct Approach for the Assessment of GVHD process. Although the early stages, such as vascular in the NOD Chimeric Model (Fig. 1B) and perivascular (Fig. 1C ) accumulation of lymphocytes prior to their detention within islets, are not
The skin, tongue, and liver are the organs most commonly used for histological evaluation of GVHD (1,25). usually noted in the insulitis assessment, their inclusion assures accurate evaluation of the endocrine pancreas in However, in the NOD chimerae the pathological alterations observed in the skin and tongue were so minimal the diabetic mouse. B10 (group 1, n = 9) and NOD (group 2, n = 10) recipipancreatic morphology remains intact. 1 MNC perivascular infiltration of the vessels adjacent ents induced a donor hemopoietic chimerism of 51.6 ± to the islets of Langerhans, while islets maintain a 2.3% and 2 ± 2.6%, respectively (Fig. 4) compared with other mouse strains studied. This is represented by a high value of the error bar on Figure 4 , group 3. that they could not be reliably quantified and scored. Only
Level of Allogeneic Chimerism in NOD Recipients the liver specimens showed a variety of histological alter-Increases With Time ations in correlation with the clinical manifestations of Another interesting and distinct feature of the NOD disease (weight loss and skin ulceration). The pathology chimerae from other, nonautoimmunity-prone strains of observed in the liver was persistent and quantifiable mice that underwent the allogeneic BMT is the increase throughout the follow-up and was in agreement with preof the level of chimerism with time when compared with viously reported characterizations of the mouse model of the initial numbers determined at 4 weeks after BMT. GVHD (26-28). Therefore, we concluded that the GVHD NOD mice at 10-11 weeks of age were subjected to assessment in the chimeric NOD mice could be limited to BMT. Recipients (n = 11) received a dose of 700 cGy the liver pathology, and for its assessment we adopted a of TBI and were transplanted with 25 × 10 6 BM cells scoring system as shown in Figure 3 and Table 2. collected from B6 euthanized donors and T cell depleted Higher Doses of the Donor Bone Marrow Cells as described in Materials and Methods. Chimerae were Are Required for MHC-Mismatched tested for the level of donor chimerism at 4 and 9 weeks Chimera Preparation in NOD Versus after BMT. In all animals the percentage of donor-Autoimmune-Resistant Recipients derived hemopoietic cells increased significantly with time, as shown in Figure 5 . The statistical significance Donor bone marrow cell number required for the establishment of the chimeric status in the NOD mice was of the donor-derived "healthy" cells superseding the endogenous hemopoietic cells in the autoimmunity-prone titrated to define a dose-based correlation with the level of the chimerism achieved. To prepare mixed allogeneic recipients was analyzed using a paired t-test. The aver- age levels of chimerism determined in NOD recipients rism at these time points demonstrated that the median values were 30.00 and 75.00, respectively, while 25th at 4 and 9 weeks after BMT were significantly different: 28.18 ± 5.03% versus 69.09 ± 6.32% (p = 0.00000645).
percentiles were 18.50 and 69.50, and 75th percentiles were 38.50 and 79.75, respectively (Fig. 5, inset) . Additional statistical analyses of the kinetics of chime- . Pathological manifestations of this field correspond to a total score of 7. Magnification ×200. (F) Zone 2 of hepatic unit representing moderate parenchymal infiltration. Score 2. Magnification ×400. (G) Portal area with a significantly damaged bile duct (score 5) and moderate periportal infiltration (score 2). Pathological manifestations of this field correspond to a total score of 7. Magnification ×400. (H) Large bile duct showing moderate bile duct epithelial cell disarrangement (score 1), minimal bile duct epithelial cell necrosis (score 1), and minimal periportal infiltration (score 1). Pathological manifestations of this field correspond to a total score of 3. Magnification ×630. 5 . Level of allogeneic chimerism in NOD mice increases with time. NOD mice at 9-12 weeks of age were sub-damage moderate 1 jected to TBI of 700 cGy and transplanted with varying numsignificant 2 bers (10 × 10 6 -25 × 10 6 ) of MHC-mismatched (B6 or BR) Bile duct damage as necrosis/apoptosis minimal 3 T-depleted BM. Chimerae were typed for the level of donor moderate 4 chimerism at 4 and 9 weeks after BMT. Each line represents significant 5 kinetics of levels of donor hemopoiesis in individual chimerae. Black and gray circles show results of PBL typing at 4 and 9 weeks after chimera preparation, respectively. The box plot graph in the upper corner represents statistical values: the boundary of the box closest to zero indicates the 25th percentile, a solid line within the box marks the median, a dotted line marks the mean, the boundary of the box farthest from zero indicates the 75th percentile, and whiskers above and below the box indicate the 90th and 10th percentiles.
Hemopoietic Chimerism Promotes Engraftment of the BM MHC-Matched Islet Allografts in the NOD Mice
To find out whether the allogeneic chimerism in our experimental setting would sustain the islet engraftment, the NOD female mice at 11-13 weeks of age (n = 10) were rendered allogeneic chimerae. For the recipient conditioning a nonlethal (700 cGy) dose of TBI was used. Recipients were reconstituted by administration of of 15 × 10 6 allogeneic (BR) and 5 × 10 6 syngeneic donor BM All animals became euglycemic the day following the cells (both T cell depleted). After 4 weeks, PBL from the chimeric animals were typed to determine the level of donor islet transplantation and remained as such for the length chimerism. In groups 1 and 2, although the identical protocol of observation (8 weeks). Additional chimerae transfor chimerism induction was applied at a similar recipient age planted with islets from third-party allogeneic donors (8-9 weeks), a 25-fold lower level of donor hemopoietic cells (BR donors, n = 7) consistently rejected the islet grafts was detected in NOD versus B10 recipients. However, it was and presented with hyperglycemia within 2 weeks of possible to increase level of chimerism in NOD recipients by doubling the dose of the allogeneic BM cells (group 3). transplantation. However, the variable level of the achieved chime-collected at 8 weeks after islet transplantation, no histological signs of graft rejection or impaired function were rism ( Table 3 , group 1) did not affect the outcome of islet transplantation. In group 2 (Table 3 , n = 3) in which observed (Fig. 6 ). animals were transplanted following the same protocol DISCUSSION as described for B6 donors with BR-derived BM plus islets grafts, the establishment of lower level (up to 1%)
Although it has been demonstrated that hemopoietic chimerism can arrest the progression of insulitis and is of chimerism did not impair the potential of chimerism to promote islet engraftment. In the transplanted islets regarded as a possible approach in treatment of diabetes, the formulation of an optimal protocol for allogeneic from the randomly chosen islet graft-bearing kidneys, Figure 6 . Islets of Langerhans from the BM-specific donor transplanted into NOD chimerae showed no recurrence of insulitis and normal insulin content. NOD chimerae were transplanted with BM donor-specific islets of Langerhans from 1 day to 1 week after BMT. Islet graft-bearing kidneys were surgically removed from randomly chosen animals from 1 day to 8 weeks after islet transplantation. Specimens were routinely processed and stained with H&E (A) and anti-insulin mAb (B). BMT in a diabetic recipient remains unclear. Two major competitive encounter with the donor-derived hemopoiesis eventually leads to progressive elimination of the aspects need to be clarified to make MHC-mismatched BMT applicable in the treatment of human diabetes. The endogenous cells. Further study is needed to verify this hypothesis, because the observed phenomenon of the re-first refers to establishing a procedure for the generation of hemopoietic chimerism that would insure the abroga-placement of the diabetic recipient's hemopoiesis by the donor-derived might be important for clinical applica-tion of the diabetes-associated autoimmune process. The second should focus on finding a strategy that provides tion of BMT in treatment of IDDM. In summary, we suggested two well-defined scoring such therapeutic effect while minimizing the side effects associated with transplantation of the immunocompetent systems and a new Index N for the assessment of the pathological characteristics of diabetogenesis and GVHD tissue.
The most adequate and employed animal model of in chimeric NOD mice. These parameters seemed to be well suited to prove that a higher number of donor BM type I diabetes used to answer these questions is the NOD mouse. This study was aimed to standardize the cells is required to induce allogeneic chimerism in NOD versus autoimmune-free chimerae, and that the level of assessment of the particular features of allogeneic chimerism in this model. donor hemopoiesis is increasing over time in this model. Also, we were able to demonstrate that in the NOD Two detailed scoring systems are proposed: one for the assessment of insulitis and another for the evaluation model a recipient conditioning resulting in as low as 1% of chimerism is sufficient to promote engraftment of the of GVHD in the recipients of allogeneic BM transplants.
To provide an adequate estimation of the overall dia-BM donor-specific islets of Langerhans. betogenic damage of the endocrine pancreas in the makes them more susceptible to apoptosis, and their
